Adipose‐derived regenerative cells and lipotransfer in alleviating breast cancer‐related lymphedema: An open‐label phase I trial with 4 years of follow‐up

Patients with breast cancer‐related lymphedema (BCRL) have reduced quality of life and arm function. Current treatments are palliative, and treatments improving lymphedema are lacking. Preclinical studies have suggested that adipose‐derived regenerative cells (ADRCs) can alleviate lymphedema. We, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jørgensen, Mads Gustaf, Toyserkani, Navid Mohamadpour, Jensen, Charlotte Harken, Andersen, Ditte Caroline, Sheikh, Søren Paludan, Sørensen, Jens Ahm
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Human Clinical Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133335/
https://www.ncbi.nlm.nih.gov/pubmed/33594819
http://dx.doi.org/10.1002/sctm.20-0394

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8133335/
https://www.ncbi.nlm.nih.gov/pubmed/33594819
http://dx.doi.org/10.1002/sctm.20-0394

Ejemplares similares